ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)


Volume 17, 9 Issues, 2017


Download PDF Flyer




Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68th of 213 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.707
5 - Year: 3.446

Upcoming Articles (E-Pub Abstracts ahead of Print)

Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects


Avineesh Singh, Preeti Patel, Vijay Patel, Deepak K Jain, Ravichandran Veerasamy, Prabodh Chandere Sharma and Harish Rajak.


View Abstract


CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies


Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi, Behzad Baradaran and Leili Aghebati-Maleki.


View Abstract


Recent Advances in Application of Poly-epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-tumor Drugs


Zhiqiang Sun, Ranglong Duan, Dejun Xing, Xuan Pang, Zhiying Li and Xuesi Chen.


View Abstract


The linkage between inflammation and immune tolerance: interfering with inflammation in cancer


Vladimir Stanislavovich Rogovskii.


View Abstract


Cathepsin D as a promising target for the discovery of novel anticancer agents


Vijaya Dubey and Suaib Luqman.


View Abstract


Studies on non-synonymous polymorphisms altering human DNA Topoisomerase II-alpha interaction with Amsacrine and Mitoxantrone: An in silico approach


Farzaneh Mohamadi Farsani, Mohamad Reza Ganjalikhany and Sadeq Vallian.


View Abstract


Advertisement
Orphan Drugs and Rare Diseases Europe 2017

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science